BioVaxys Technology

(OTC) BVAXF

Current Price$0.16

Market Cap$4.52M

Since IPO (2020)-95%

5 Year-92%

1 Year-43%

1 Month-7%

BioVaxys Technology Financials at a Glance

Market Cap

$4.52M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$6.04M

EPS (TTM)

-$0.16

P/E Ratio

-0.97

Dividend

$0.00

Beta (Volatility)

0.17 (Low)

Dividend

$0.00

Beta (Volatility)

0.17 (Low)

Price

$0.16

Volume

29,425

Open

$0.14

Price

$0.16

Volume

29,425

Open

$0.14

Previous Close

$0.16

Daily Range

$0.11 - $0.16

52-Week Range

$0.02 - $0.30

Estimated Earnings Date

Mar 31, 2025

Dividend

$0.00

Beta (Volatility)

0.17 (Low)

Price

$0.16

Volume

29,425

Open

$0.14

Previous Close

$0.16

Daily Range

$0.11 - $0.16

52-Week Range

$0.02 - $0.30

Estimated Earnings Date

Mar 31, 2025

BVAXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioVaxys Technology

Industry

Pharmaceuticals

Sector

Health Care

CEO

James Christopher Passin

Website

www.biovaxys.com

Headquarters

Etobicoke, BC V6C 1L6, CA

BVAXF Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

92%

Return on Assets

-2%

Earnings Yield

-1.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.52M

Shares Outstanding

29.15M

Volume

29.43K

Avg. Volume

106.36K

Financials (TTM)

Gross Profit

CA$0.00

Operating Income

-CA$3.12M

EBITDA

-CA$2.36M

Operating Cash Flow

-CA$1.86M

Capital Expenditure

-CA$1.06M

Free Cash Flow

-CA$2.92M

Cash & ST Invst.

CA$211.81K

Total Debt

CA$68.08K

BioVaxys Technology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

CA$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.52M

N/A

Market Cap/Employee

$1.51M

N/A

Employees

N/A

Net Income

-CA$910.06K

+23.3%

EBITDA

-CA$656.85K

+18.1%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Total Cash

CA$4.08K

-99.2%

Total Debt

CA$133.72K

+64.7%

Accounts Receivable

CA$0.00

-100.0%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$133.72K

+64.7%

Return on Assets

-2.38%

N/A

Return on Invested Capital

92.14%

N/A

Free Cash Flow

-CA$1.06M

-156.3%

Operating Cash Flow

-CA$1.06M

-156.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

KNBIFKane Biotech Inc.

KNBIFKane Biotech Inc.$0.03+0.00%

BIXTBioxytran, Inc.

BIXTBioxytran, Inc.$0.03-1.94%

BICXBioCorRx Inc.

BICXBioCorRx Inc.$0.34-8.92%

LOBEFLobe Sciences Ltd.

LOBEFLobe Sciences Ltd.$0.01-11.84%

BZYRBurzynski Research Institute, Inc.

BZYRBurzynski Research Institute, Inc.$0.01+0.00%

THERTheralink Technologies, Inc.

THERTheralink Technologies, Inc.$0.00+0.00%

CUBTCurative Biotechnology, Inc.

CUBTCurative Biotechnology, Inc.$1.45-5.84%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.98-0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.35+0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$79.93-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.45-0.03%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$729.86-0.02%

ONDSOndas

ONDSOndas$9.21-0.03%

RXTRackspace Technology

RXTRackspace Technology$6.21+0.05%

Questions About BVAXF

What is the current price of BioVaxys Technology?

BioVaxys Technology is trading at $0.16 per share.

What is the 52-week range for BioVaxys Technology?

Over the past 52 weeks, BioVaxys Technology has traded between $0.02 and $0.30.

How much debt does BioVaxys Technology have?

As of the most recent reporting period, BioVaxys Technology reported total debt of CA$96.72K.

How much cash does BioVaxys Technology have on hand?

BioVaxys Technology reported CA$2.95K in cash and cash equivalents in its most recent financial results.

What is BioVaxys Technology’s dividend yield?

BioVaxys Technology does not currently have a dividend yield.

BioVaxys Technology

BioVaxys Technology Financials at a Glance

BVAXF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioVaxys Technology

BVAXF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioVaxys Technology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BVAXF

What is the current price of BioVaxys Technology?

What is the 52-week range for BioVaxys Technology?

How much debt does BioVaxys Technology have?

How much cash does BioVaxys Technology have on hand?

What is BioVaxys Technology’s dividend yield?

Premium Investing Services